Rewards

Roivant Sciences Ltd. Common Shares (ROIV)

Underlying price

$36.05

-1.21% today

Stock stats

Market cap
$26.3B
Previous close
$36.49
Open
$36.66
Day's range
$35.66 – $36.91
52-week range
$18.27 – $42.50
Volume
9.86M
Avg volume
7.50M
P/E ratio
-
EPS
-$0.37
Dividend yield
-
Beta
1.20
Next earnings
Nov 9, 2026

About Roivant Sciences Ltd. Common Shares

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Ticker
ROIV
Asset class
Equity
Tokenized by
1 issuer
Sector
Healthcare
Industry
Pharmaceutical Preparations
Employees
721

Roivant Sciences Ltd. Common Shares FAQ

ROIV is Roivant Sciences Ltd. Common Shares stock, issued on Solana as a token that tracks the listed share. Each issuer mints its own version, so Roivant Sciences Ltd. Common Shares trades here as one token.